Citations 1
Post‐ FDA Approval Experience With Momelotinib in JAK Inhibitor‐Naïve Myelofibrosis: Focus on Anemia Response and Treatment‐Emergent Nephropathy and Perip
Tefferi, Ayalew, Abdelmagid, Maymona, Palmer, Jeanne , Al‐Kali, Aref, Yi, Cecilia Y. Arana , Matin, Aasiya, Alkhateeb, Hassan B., Badar, Talha , Bashir, Yassin, Reichard, Kaaren K. , He, Rong , Pardanani, Animesh , Gangat, Naseema, Tefferi, Ayalew , Al-Kali, Aref , Gangat, Naseema , Badar, Talha , Tefferi, Ayalew , Al‐Kali, Aref , Yi, Cecilia Arana , Matin, Aasiya , Alkhateeb, Hassan B. , Gangat, Naseema
American Journal of Hematology | January 8, 2026 | Volume: 101 | Issue: 3 | Pages: 570-576
